Lanean...
Chemoresponse Assay in Head and Neck Cancer Patients: A Three-Year Follow Up
INTRODUCTION: The majority of patients with advanced head and neck cancer receiving chemotherapy show partial response or frank resistance. Therefore, assessing the individuals’ tumour reactivity to the eligible chemotherapeutic compounds carries the potential of personalizing the patient treatment...
Gorde:
| Argitaratua izan da: | J Clin Diagn Res |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
JCDR Research and Publications (P) Limited
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483792/ https://ncbi.nlm.nih.gov/pubmed/28658890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/24802.9816 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|